SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-009597
Filing Date
2015-02-12
Accepted
2015-02-12 17:23:33
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a14-26398_110q.htm 10-Q 679313
2 EX-10.2 a14-26398_1ex10d2.htm EX-10.2 449895
3 EX-31.1 a14-26398_1ex31d1.htm EX-31.1 10628
4 EX-31.2 a14-26398_1ex31d2.htm EX-31.2 10629
5 EX-32.1 a14-26398_1ex32d1.htm EX-32.1 4243
6 EX-32.2 a14-26398_1ex32d2.htm EX-32.2 4648
  Complete submission text file 0001104659-15-009597.txt   5495793

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ctrv-20141231.xml EX-101.INS 594061
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctrv-20141231.xsd EX-101.SCH 38899
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctrv-20141231_cal.xml EX-101.CAL 26862
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctrv-20141231_def.xml EX-101.DEF 179176
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ctrv-20141231_lab.xml EX-101.LAB 357947
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctrv-20141231_pre.xml EX-101.PRE 292519
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55020 | Film No.: 15607606
SIC: 2834 Pharmaceutical Preparations